MedTrace Logo

Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters

NCT03408041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2018-01-23

No results posted yet for this study

Summary

The early diagnosis of Alzheimer's disease is essential to enable patients to have access to the available treatments. However, there is a delay between the diagnosis and the onset of symptoms, which can range from 1 year to more than 5 years. In clinical practice, the hippocampal volume, measured by the Scheltens index, is currently used as a marker of the progression of the disease.

The purpose of this study is to determine whether the patient's sex, age and ethnicity can influence the delay in the expression of cognitive troubles reported by the family at the first medical consultation, as well as to determine if there is a correlation between the delay reported by the family and the Scheltens index.

Conditions

  • Alzheimer Disease

Interventions

OTHER

Medical file data extraction

Medical file data extraction

Sponsors & Collaborators

  • Murielle Surquin

    lead OTHER

Principal Investigators

  • Florence Benoit, MD · CHU Brugmann

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2017-10-01
Completion
2017-10-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03408041 on ClinicalTrials.gov